Search
for
Sort by
Research 421–450 of 1000+
- The necessity of investigations to clarify sex and racial disparities in pathophysiology of Long COVID
- Cognitive, emotional, physical, and behavioral stress-related symptoms and coping strategies among university students during the third wave of COVID-19 pandemic
- In response to the letter to the editor by Soha Ghanian et al. re our publication “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males”
- Rare and common manifestations of COVID‐19 in children
- COVID-19 pandemic: what about the gonads?
- Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
- Persistence of Long-COVID symptoms in a heterogenous prospective cohort
- Covid induced telogen effluvium (CITE): An insight
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Dermoscopy-assisted prevalence of hair loss after COVID-19 vaccination among an Egyptian population: a cross-sectional study
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study
- A prospective cross-sectional study on post COVID-19 hair loss at a tertiary care hospital
- Androgen receptor genetic variant predicts COVID‐19 disease severity: a prospective longitudinal study of hospitalized COVID‐19 male patients
- COVID-19 and hypopituitarism
- The role of autologous micrografts injection from the scalp tissue in the treatment of COVID‐19 associated telogen effluvium: Clinical and trichoscopic evaluation
- Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?
- Skin amidst COVID ‐19 pandemic
- Self-reported long COVID-19 symptoms are rare among vaccinated healthcare workers
- Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients
- Estimating long COVID-19 prevalence across definitions and forms of sample selection
- Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia
- Alopecia universalis after injection of messenger RNA COVID-19 vaccine. A case report
- Corona With Lyme: A Long COVID Case Study
- Prominent Cutaneous Manifestation of COVID-19: A Case Report
- Long COVID and Post-Covid Conditions (PCC) in 2025
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
- Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis
- COVID-19 in Africa: an ovarian victory?